Brazil looks to new Pfizer contract to speed up vaccinations

By Eduardo Simões SAO PAULO (Reuters) - Brazil is close to signing a second contract with Pfizer Inc for another 100 million doses of its COVID-19 vaccine, of which 35 million shots are due to be delivered in October, Brazil's Health Minister Marcelo Queiroga said on Monday. That raises to 200 million doses of the Pfizer shot for Brazil this year, he said, aimed at relieving the shortage of vaccines contributing to the world's second-deadliest outbreak outside the United States. Rio de Janeiro, Brazil's second-largest city, announced over the weekend that it was delaying second doses of CoronaVac, the vaccine made by China's Sinovac Biotech, because it was running out of shots.

Reuters May 04, 2021 03:10:48 IST
Brazil looks to new Pfizer contract to speed up vaccinations

Brazil looks to new Pfizer contract to speed up vaccinations

By Eduardo Simões

SAO PAULO (Reuters) - Brazil is close to signing a second contract with Pfizer Inc for another 100 million doses of its COVID-19 vaccine, of which 35 million shots are due to be delivered in October, Brazil's Health Minister Marcelo Queiroga said on Monday.

That raises to 200 million doses of the Pfizer shot for Brazil this year, he said, aimed at relieving the shortage of vaccines contributing to the world's second-deadliest outbreak outside the United States.

Rio de Janeiro, Brazil's second-largest city, announced over the weekend that it was delaying second doses of CoronaVac, the vaccine made by China's Sinovac Biotech, because it was running out of shots. The second dose will only be applied every other day until more supplies arrive from the finishing facility at the Butantan biomedical center in Sao Paulo.

Most COVID-19 shots administered so far in Brazil have been CoronaVac, but the Butantan finishing line halted two weeks ago due to delayed shipments of active ingredients from China.

A new load of the ingredient, enough for 5 million doses of CoronaVac, arrived in Brazil on April 19.

So far, Butantan has delivered 42 million doses of CoronaVac to the national immunization program, compared to 26.5 million doses of the AstraZeneca PLC vaccine filled and finished by Fiocruz biomedical center in Rio de Janeiro.

Brazil's Health Ministry received its first 1 million doses of the Pfizer vaccine last week.

Speaking to industry leaders in Sao Paulo, Queiroga said the second contract with Pfizer would double the 100 million doses already signed for the vaccine, which are due for delivery by the end of September.

Queiroga blamed what he saw as failures in intensive care wards for the large toll caused by COVID-19 in Brazil, which has passed 407,000 confirmed deaths.

"We cannot accept that out of every 10 patients who are intubated, eight die. That is why we have so many deaths, because health care does not give the answer we expect from it," said Queiroga, who took office in March as Brazil's fourth health minister tackling its worsening pandemic.

On Monday, a parliamentary inquiry began to hear testimony in a Senate investigation into the handling of the coronavirus crisis by the government of far-right President Jair Bolsonaro, who has repeatedly denied the gravity of the virus, opposed lockdowns and was slow to ensure vaccine supplies last year.

(Reporting by Eduardo Simoes; Additional reporting by Rodrigo Viga in Rio de Janeiro; Writing by Anthony Boadle; Editing by Aurora Ellis)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

China's Ximalaya, Qiniu file for U.S. IPOs
News & Analysis

China's Ximalaya, Qiniu file for U.S. IPOs

(Reuters) -Ximalaya, backed by China's Tencent Holdings, filed for an initial public offering (IPO) in the United States on Friday, cashing in on growing demand as more people tune in to podcasts while staying at home during the pandemic. China's Qiniu Ltd, a cloud-based platform-as-a-service provider backed by Alibaba Group Holding Ltd, also filed paperwork for a U.S. IPO

Donerail pushes gaming headset maker Turtle Beach to explore a sale - sources
News & Analysis

Donerail pushes gaming headset maker Turtle Beach to explore a sale - sources

By Greg Roumeliotis (Reuters) - Donerail Group, an investment firm led by former activist hedge fund Starboard Value LP executive Will Wyatt, has amassed a stake in Turtle Beach Corp and is pushing the maker of gaming headsets to explore a sale, people familiar with the matter said on Friday. The move represents a bet that Turtle Beach could attract acquisition interest from peers such as Corsair Gaming Inc and GN Store Nord A/S, as the video game market continues to benefit from people looking for entertainment options at home during the COVID-19 pandemic

Analysis: New meme stocks swing as shorts and retail investors face off again
Business

Analysis: New meme stocks swing as shorts and retail investors face off again

By John McCrank, Saqib Iqbal Ahmed and Lawrence Delevingne NEW YORK (Reuters) - Recent volatility in a handful of so-called meme stocks is putting the spotlight back on the tussle between individual investors and short sellers, months after a wild ride in GameStop captivated Wall Street’s attention. Stocks that have notched big swings this month include laser-manufacturer MicroVision Inc, a favorite on Reddit’s popular WallStreetBets forum, whose shares have risen as much as 170% since April 20 before tumbling in recent days